HomeLXEO • NASDAQ
add
Lexeo Therapeutics Inc
Previous close
$5.18
Day range
$4.90 - $5.25
Year range
$1.45 - $11.72
Market cap
279.73M USD
Avg Volume
355.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.97M | 128.43% |
Net income | -26.10M | -22.91% |
Net profit margin | — | — |
Earnings per share | -0.68 | -5.77% |
EBITDA | -30.55M | -30.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 132.89M | -24.05% |
Total assets | 176.07M | -8.30% |
Total liabilities | 37.85M | 39.88% |
Total equity | 138.22M | — |
Shares outstanding | 54.00M | — |
Price to book | 2.02 | — |
Return on assets | -50.85% | — |
Return on capital | -62.72% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -26.10M | -22.91% |
Cash from operations | -27.22M | -35.07% |
Cash from investing | -39.17M | -17,869.72% |
Cash from financing | 72.96M | 24,972.16% |
Net change in cash | 6.57M | 132.71% |
Free cash flow | -16.69M | -23.00% |
About
Founded
2017
Website
Employees
61
